MON results not terribly good at all at $233m loss for Q4 which was $60m worse than LY....massive impact from glyphosphate....marginally exceeded analyst expectations for Q4 but they had been lowered significantly so SP might rise a few % but it had dropped back from $80 to $75 in the past week or two. Sinochem won't pay $13 after they complete this further 5 weeks of due diligence, that heads of agreement document not worth much. My tip is $12-$12.50 if it does go ahead!
Unless it falls back to $11 or under I am staying away from it. It will be ages before this one gets sorted out....could put my money to work elsewhere for a few months.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.46 |
Change
-0.030(1.20%) |
Mkt cap ! $942.2M | |||
| Open | High | Low | Value | Volume |
| $2.50 | $2.53 | $2.46 | $2.657M | 1.071M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 61684 | $2.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.49 | 27124 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| NUF (ASX) Chart |